Chitra R. Natalie - Eli Lilly and Company

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 14 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

53143 Clinical Measures of Improvement in Atopic Dermatitis Are Correlated with Reductions in Relevant Biomarkers in Patients Treated with Lebrikizumab

Emma Guttman-Yassky,Angela Okragly, Zhe Sun,Brian J. Nickoloff,Chitra R. Natalie,Gaia Gallo,Eric Wolf,Kilian Eyerich,Monica Aparici,Robert J. Benschop

Journal of the American Academy of Dermatologyno. 3 (2024): AB160-AB160

引用0浏览0引用

Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population

Jonathan Corren,Stanley J. Szefler,Ellen Sher,Phillip Korenblat,Weily Soong,Nicola A. Hanania,Gary Berman,Guy Brusselle,Ralph Zitnik,Chitra R. Natalie,Luna Sun,Kimberly Siu,Wen-Shuo Wu,Peter Lio,April W. Armstrong

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE（2024）

引用0浏览0WOS引用

Conjunctivitis Does Not Increase with Longer Duration of Lebrikizumab Exposure in Patients with Moderate-to-Severe Atopic Dermatitis

April Armstrong,Andreas Wollenberg,Marjolein de Bruin-Weller,Peter Lio,Chitra R. Natalie,Fangyi Zhao,Amber Reck Atwater,Gemma Jimenez,Chia-Yu Chu,Christian Vestergaard

BRITISH JOURNAL OF DERMATOLOGY (2024): II5-II6

引用0浏览0引用

EASI 90 Response Sustained Up to 38 Weeks after Lebrikizumab Withdrawal Despite Negligible Serum Concentrations

Jonathan Silverberg,Thomas Bieber,Kilian Eyerich,April W. Armstrong, Brian J. Nickoloff,Chitra R. Natalie,Gaia Gallo,Angela Okragly,Chenjia Xu,Brian Moser,Maria Jose Rueda,Hany Elmaraghy,Ozge Uluckan,Johann E. Gudjonsson

BRITISH JOURNAL OF DERMATOLOGY (2024)

引用0浏览0引用

493 - Lebrikizumab Does Not Impact Vaccine-Induced Immune Responses: Results from a Phase 3 Study in Adult Patients with Moderate-to-severe Atopic Dermatitis

Jennifer Soung,Vivian Laquer,Joseph F Merola,Seth Forman,Hany Elmaraghy,Eric Meskimen,Chaoran Hu,Chitra R Natalie,Evangeline Pierce,Hitoe Torisu-Itakura,Esther Garcia Gil, Abel D Jarell

British Journal of Dermatology（2024）

引用0浏览0引用

Efficacy and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: 52-Week Results of Two Randomized, Double-Blinded, Placebo-Controlled Phase 3 Trials (advocate1 and ADvocate2)

Andrew Blauvelt,Jacob P. Thyssen,Emma Guttman-Yassky,Thomas Bieber,Jose Manuel Carrascosa,Eric Simpson,David Rosmarin,Hany Elmaraghy,Eric Meskimen,Chitra R. Natalie,Zhuqing Liu,Chenjia Xu,Evangeline Pierce,MaryAnn Morgan-Cox,Jonathan Silverberg

British journal of dermatology/British journal of dermatology, Supplementno. Supplement_2 (2023)

引用2浏览0引用

Lebrikizumab Decreases Inflammatory Biomarkers in Patients with Asthma: Data from Randomized Phase 3 Trials (LAVOLTA I and II)

Stanley Szefler,Jonathan Corren,Jonathan Silverberg,Angela Okragly, Zhe Sun,Chitra Natalie,Ralph Zitnik,Kimberly Siu,Andrew Blauvelt

Journal of Allergy and Clinical Immunologyno. 2 (2023)

引用2浏览0引用

Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-severe Atopic Dermatitis: an Open-Label Study

Amy Paller,Carsten Flohr,Lawrence F. Eichenfield,Alan Irvine, Ana Pinto Correia,Chitra R. Natalie,Evangeline Pierce,Renata Gontijo Lima,Vivian Laquer,Stephan Weidinger

Journal of the American Academy of Dermatologyno. 3 (2023): AB84-AB84

引用0浏览0引用

Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study

Amy S. Paller,Carsten Flohr,Lawrence F. Eichenfield,Alan D. Irvine,Jamie Weisman,Jennifer Soung, Ana Pinto Correia,Chitra R. Natalie,Claudia Rodriguez Capriles,Evangeline Pierce,Sarah Reifeis,Renata Gontijo Lima, Clara Armengol Tubau,Vivian Laquer,Stephan Weidinger

Dermatology and Therapy（2023）

引用0浏览0WOS引用

Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials

Andrew Blauvelt,Jacob P Thyssen,Emma Guttman-Yassky,Thomas Bieber,Esther Serra-Baldrich,Eric Simpson,David Rosmarin,Hany Elmaraghy,Eric Meskimen,Chitra R Natalie,Zhuqing Liu,Chenjia Xu,Evangeline Pierce,MaryAnn Morgan-Cox,Esther Garcia Gil,Jonathan I Silverberg

The British journal of dermatology（2023）

引用10浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn